U.S. Markets closed

Galena Biopharma, Inc. (GALE)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6055+0.04 (+8.01%)
At close: 4:00PM EDT

0.6077 0.00 (0.36%)
After hours: 7:56PM EDT

People also watch
IMUCCYTRINOCLDXTHLD
Full screen
Previous Close0.5606
Open0.5610
Bid0.3750 x 100
Ask0.8200 x 12500
Day's Range0.5609 - 0.6099
52 Week Range0.1600 - 4.7500
Volume1,699,290
Avg. Volume690,168
Market Cap22.67M
Beta2.19
PE Ratio (TTM)-0.46
EPS (TTM)-1.31
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • AbbVie and J&J Present Positive Imbruvica Leukemia Data
    Zackslast month

    AbbVie and J&J Present Positive Imbruvica Leukemia Data

    AbbVie Inc. (ABBV) recently announced positive data from a pooled analysis of three phase III studies evaluating its cancer drug, Imbruvica (ibrutinib).

  • Associated Presslast month

    Galena Biopharma reports 1Q loss

    On a per-share basis, the San Ramon, California-based company said it had a loss of 45 cents. Losses, adjusted to account for discontinued operations, came to 9 cents per share. In the final minutes of ...

  • GlobeNewswirelast month

    Galena Biopharma Reports First Quarter 2017 Financial Results

    SAN RAMON, Calif., May 10, 2017-- Galena Biopharma, Inc., a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results ...